Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
0.2 (1y: -27%)
Market Cap 33.45 M P/E(ttm)
Enterprise Value 2.96 M P/B 0.74
HEB- AMEX (USA)
Hemispherx Biopharma, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$0.20
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M33.4Revenue $M0.2Net Margin (%)-8,147.4Z-Score-4.2
Enterprise Value $M-10.1EPS $-0.1Operating Margin %-9,549.3F-Score3
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-8,147.4Higher ROA y-yN
Price/Book0.710-y EBITDA Growth Rate %0Quick Ratio6.1Cash flow > EarningsY
Price/Sales1615-y EBITDA Growth Rate %-3.6Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-30.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-38.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M167ROI % (ttm)-38.1Gross Margin Increase y-yN

Gurus Latest Trades with HEB

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.

No Entry found!
Total Records: 0

HEB is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Premium Most recent portfolio changes are included for Premium Members only!


HEB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STRAYER DAVID RMedical Director 2012-05-18Buy50,000$0.26-23.08view
Lander Russel JVP of Process/QualityAssurance 2011-03-01Buy50,000$0.46-56.52view
Lander Russel JVP of Process/QualityAssurance 2010-08-23Buy4,910$0.51-60.78view
CARTER WILLIAM ACEO, 10% Owner 2010-08-10Sell377,388$0.49-59.18view
STRAYER DAVID RMedical Director 2010-06-23Sell50,900$0.55-63.64view
STRAYER DAVID RMedical Director 2010-06-16Buy230,586$0.57-64.91view
Bernhardt Charles Thomas IIICFO 2010-06-15Sell87,794$0.59-66.1view
Springate Wayne S.Vice President of Operations 2010-06-15Sell83,104$0.59-66.1view
CARTER WILLIAM ACEO, 10% Owner 2010-06-11Buy500,000$0.66-69.7view
Springate Wayne S.Vice President of Operations 2009-12-15Buy877$0.56-64.29view

Press Releases about HEB:

Quarterly/Annual Reports about HEB:

News about HEB:

Articles On GuruFocus.com
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-K/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Nov 08 2010 
Weekly CEO Sells Highlight: Hemispherx Biopharma Inc, ADESA Inc, Entergy Corp, and Danaher Corp. Aug 15 2010 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Aug 06 2010 
Hemispherx Biopharma Inc (HEB) CEO William A Carter buys 500,000 Shares Jul 01 2010 
Weekly CFO Buys Highlight: Wireless Telecom Group, ValueVision Media, American River Bankshares, Hem Dec 13 2009 
Hemispherx Biopharma Inc (HEB) CFO Charles Thomas Iii Bernhardt buys 2,000 Shares Dec 08 2009 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK